# Stereotactic Arrhythmia Radioablation for Ventricular Tachycardia (StAR-VT)

> **NCT05258422** · PHASE2 · ENROLLING_BY_INVITATION · sponsor: **McGill University Health Centre/Research Institute of the McGill University Health Centre** · enrollment: 9 (estimated)

## Conditions studied

- Ventricular Tachycardia
- Arrhythmia
- Arrhythmic Storm
- Radiation Toxicity

## Interventions

- **RADIATION:** stereotactic body radiotherapy, 20 Gy in 1 fraction

## Key facts

- **NCT ID:** NCT05258422
- **Lead sponsor:** McGill University Health Centre/Research Institute of the McGill University Health Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2023-07-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2031-12-31
- **Target enrollment:** 9 (ESTIMATED)
- **Last updated:** 2025-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05258422

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05258422, "Stereotactic Arrhythmia Radioablation for Ventricular Tachycardia (StAR-VT)". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT05258422. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*